Overview:
Argon laser therapy for glaucoma is a well-established ophthalmic laser treatment designed to reduce intraocular pressure (IOP) by improving the drainage of aqueous humor (the fluid inside the eye). The procedure, known as Argon Laser Trabeculoplasty (ALT), uses a precise argon laser beam to target and stimulate the trabecular meshwork — the primary drainage tissue of the eye. By applying controlled burns to specific areas of the meshwork, the laser enhances fluid outflow and reduces IOP, helping to prevent progressive optic nerve damage and vision loss. Argon laser treatment is most commonly used in patients with open-angle glaucoma, particularly when medications alone are insufficient or poorly tolerated. It is an outpatient, minimally invasive, and highly effective procedure that often delays or eliminates the need for surgical intervention.

What to Expect:

Symptoms:
Patients who may benefit from argon laser treatment usually experience signs of glaucoma or have elevated intraocular pressure that persists despite medical management. Symptoms may include:

• Gradual peripheral (side) vision loss
• Blurred or hazy vision
• Headache or eye pressure sensations
• Difficulty seeing in dim light
• Halos around lights
  In many cases, glaucoma is asymptomatic in its early stages, making regular eye examinations essential for timely detection and management.

Diagnosis:
Before performing argon laser therapy, ophthalmologists carry out a comprehensive evaluation to confirm glaucoma and assess the structure of the eye’s drainage system. Common diagnostic tests include:

• Tonometry: Measures intraocular pressure.
• Gonioscopy: Evaluates the angle where the iris meets the cornea and confirms an open-angle configuration.
• Slit-lamp examination: Inspects the anterior segment and drainage tissue.
• Optic nerve assessment and OCT imaging: Detects glaucomatous damage.
• Visual field testing: Identifies loss of peripheral vision.

Once the diagnosis of open-angle glaucoma is established, and medications fail to achieve target IOP, argon laser trabeculoplasty becomes an effective next-line treatment.

Treatment (Procedure Description):

1. Preparation:

• The procedure is performed under topical anesthesia using numbing eye drops.
• A special contact lens is placed on the eye to focus the laser precisely on the trabecular meshwork.

2. Laser Application:

• The argon laser delivers small, low-energy thermal burns to selected areas of the trabecular meshwork, typically covering 180° to 360° of the angle.
• These controlled burns cause microscopic tissue contraction, widening the drainage spaces and improving the outflow of aqueous fluid.
• The procedure usually takes 10–15 minutes per eye and is painless.

3. Post-Procedure:

• The patient rests for a short observation period.
• Eye pressure is checked shortly after the treatment, as a transient rise in IOP may occur.
• Anti-inflammatory or IOP-lowering drops are prescribed for a few days post-procedure.
• Most patients can resume normal activities within 24 hours.

What to Consider:

Benefits:

• Minimally invasive and performed in an outpatient setting.
• Quick recovery time and minimal discomfort.
• Effectively reduces intraocular pressure in 75–85% of patients.
• May reduce or eliminate the need for long-term glaucoma medications.
• Can delay or prevent the need for incisional surgery.

Risks and Complications:
Although generally safe, potential side effects may include:

• Temporary rise in IOP immediately after the procedure.
• Mild redness, irritation, or sensitivity to light.
• Inflammation of the anterior chamber (transient iritis).
• Rarely, scarring or reduced effectiveness over time (laser effect may diminish after several years).
• Small risk of peripheral anterior synechiae (adhesions in the drainage angle).

Recovery and Aftercare:

• Patients may experience mild discomfort or blurred vision for 24–48 hours.
• Anti-inflammatory eye drops are used for several days to control inflammation.
• Follow-up visits are essential to monitor IOP, usually at 1 hour, 1 week, and 4–6 weeks after treatment.
• The effect of ALT typically lasts 3–5 years, after which the procedure can sometimes be repeated or replaced with selective laser trabeculoplasty (SLT), a gentler variant using different laser energy.

Other Information:

Indications:
Argon laser trabeculoplasty is primarily indicated for:

• Primary open-angle glaucoma (POAG)
• Pseudoexfoliation glaucoma
• Pigmentary glaucoma
• Patients noncompliant with or intolerant to medications
• Adjunct therapy before considering surgical options

Alternatives and Evolution:
While ALT remains effective, newer techniques such as Selective Laser Trabeculoplasty (SLT) and Micropulse Laser Trabeculoplasty (MLT) use lower energy and minimize thermal damage, allowing safer repeat treatments.

Prognosis:
When performed in appropriate candidates, argon laser therapy provides significant and sustained IOP reduction. Many patients achieve stable vision and delayed disease progression for several years. However, regular monitoring remains critical, as glaucoma can continue to progress silently.

Conclusion:
Argon laser therapy for glaucoma (Argon Laser Trabeculoplasty) is a safe, effective, and time-tested procedure that plays a key role in managing open-angle glaucoma. By enhancing fluid drainage through the trabecular meshwork, it helps lower intraocular pressure and protect the optic nerve from further damage. With minimal discomfort, quick recovery, and proven long-term benefits, argon laser treatment offers an excellent intermediate option between medical therapy and conventional surgery, helping patients maintain vision and ocular health for years to come.

‍